The migration and invasion capacities of cancer cells were strengthened because of declining the CREBZF level in si-CREBZF + miR-423-5p inhibitor group compared with that in the miR-423-5p inhibitor group (Figure 8e-g). Here, CREBZF is linked to cancer.